FDA Inspection
Allergan Sales LLCAllergan Sales LLC – FDA Inspection, Dec 12, 2025
Record Details
This FDA Inspection record concerns Allergan Sales LLC, with an inspection on December 12, 2025, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · b8bb45b2-d6e9-4528-b22f-4703e33e153a
Inspection Facts
- Inspection number
- 1283434
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.170(b)Reserve drug product sample quantity - all tests
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Allergan Sales LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 29, 2019 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| May 20, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Allergan Sales LLC
- FDA Inspection 1147251 - 2021-06-24
- FDA Inspection 1097944 - 2019-07-29
- FDA Inspection 978858 - 2016-05-20
- FDA Inspection 943994 - 2015-09-22
- FDA Inspection 808509 - 2012-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.